长非编码RNA 01296在人类恶性瘤中的新兴作用
Lei Luo1, Fan Yang1, Xiaoping Fu1
1Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430070, P.R. China.
Current molecular medicine
|February 4, 2025
概括
长非编码RNA 01296 (LINC01296) 与癌症进展有关. 本综述强调LINC01296作为各种人类恶性瘤的潜在生物标志物和治疗点.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 是生物过程中的关键调节者.
- 包括LINC01296在内的lncRNAs的失调与癌症的发展和进展有关.
- 人类癌症中LINC01296经常过度表达,与疾病进展相关.
研究的目的:
- 综合审查LINC01296在人类癌症中的作用和机制.
- 探索LINC01296作为生物标志物和治疗点的临床意义.
- 总结最近在了解LINC01296在恶性瘤中的功能方面取得的进展.
主要方法:
- 在癌症中研究LINC01296的研究文献综述.
- 分析LINC01296表达水平及其与癌症预后的相关性.
- 检查LINC01296的分子机制,包括其作为竞争性内源RNA (ceRNA) 的作用.
主要成果:
- LINC01296 失调影响癌细胞的增殖,细胞亡,侵袭,转移和细胞循环.
- LINC01296充当ceRNA,调节基因和信号通路,对癌症至关重要.
- 升高的LINC01296水平与各种癌症的预后较差有关.
结论:
- LINC01296在人类癌症的发病和进展中发挥着重要作用.
- LINC01296证明了作为癌症患者可靠的预后生物标志物的潜力.
- LINC01296代表了新型癌症干预的有前途的治疗标.
相关概念视频
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
RNA Splicing
55.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
55.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K


